Infectious Disease Archives | Certara

Publication

Advancing pharmacometrics in Africa – Transition from capacity development toward job creation

This CPT article showcases, the Applied Pharmacometrics Training (APT) program, launched in 2021 by Pharmacometrics…

Danielle PillsburyDecember 9, 2024

Poster

Population pharmacokinetic modeling of TBA-7371 in healthy participants describes apparent auto-induction of clearance and predicts PK in participants with Mycobacterium tuberculosis.

Danielle PillsburyNovember 22, 2024

Publication

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Danielle PillsburyJanuary 17, 2020

Publication

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Danielle PillsburyJanuary 17, 2020

Poster

Population Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Paediatric Population

Danielle PillsburyJune 24, 2019

Poster

Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV

Danielle PillsburyJune 24, 2019

Publication

A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole

Danielle PillsburyJuly 1, 2018

Publication

Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children

Danielle PillsburyJune 4, 2018

Publication

Population Pharmacokinetics of Intravenous Linezolid in Premature Infants

Danielle PillsburyApril 9, 2018

Publication

Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations

Danielle PillsburyApril 1, 2018

© 2025 Certara. All Rights Reserved. | Privacy policy